These two T-ALL cell lines expressing different levels of UCP2 provided a means to address the influence of UCP2 on two important aspects of T-ALL cell biology: proliferation rate and oxidative capacity. This evidence concerns the gene UCP2 and acute lymphoblastic leukemia.